Switch to:
Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
Cash Flow for Capital Expenditures
$-866 Mil (TTM As of Jun. 2015)

Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Teva Pharmaceutical Industries Ltd's cash flow for capital expenditures for the three months ended in Jun. 2015 was $-354 Mil. Its cash flow for capital expenditures for the trailing twelve months (TTM) ended in Jun. 2015 was $-866 Mil.


Definition

Cash flow for capital expenditures refers to the cash generated minus spent for a company to acquire or upgrade physical assets such as property, industrial buildings or equipment.

Teva Pharmaceutical Industries Ltd Cash Flow for Capital Expenditures for the trailing twelve months (TTM) ended in Jun. 2015 was -212 (Sep. 2014 ) + -300 (Dec. 2014 ) + 0 (Mar. 2015 ) + -354 (Jun. 2015 ) = $-866 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Teva Pharmaceutical Industries Ltd Annual Data

Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14
Cash Flow_CPEX -310-390-542-681-719-710-1,053-1,104-1,031-929

Teva Pharmaceutical Industries Ltd Quarterly Data

Mar13Jun13Sep13Dec13Mar14Jun14Sep14Dec14Mar15Jun15
Cash Flow_CPEX -264-225-228-314-225-417-212-3000-354
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK